Getz gets Port-Access in Japan:
This article was originally published in Clinica
Executive Summary
Getz is to have exclusive distribution rights to Heartport's Port-Access minimally-invasive cardiac surgery systems in Japan. California-based Getz will obtain regulatory approvals and reimbursement for the systems as well as training Japanese surgical teams. Heartport's product allows surgeons to perform heart operations through a small incision between the ribs. Some 900,000 people in Japan have ischemic heart disease and more than 30,000 people undergo open heart surgery annually. Getz claims to be the largest healthcare export marketing and services company in the US with offices in 23 countries.